Why Cerebras Systems Inc. (CBRS) Stock Rose 11.2% on Nov 13, 2026
as of yesterday, 4:31 PM ET
The reason we found
Strong earnings and Microsoft deal lift Cerebras shares
Cerebras reported record third-quarter core revenue, its first core profit, and stronger financial guidance, while announcing a Microsoft cloud partnership. Those developments improve the growth outlook and diversify revenue beyond OpenAI, plausibly driving the stock’s 11.09% gain despite delays affecting part of its OpenAI contract.
earnings and strategic partnershiphigh confidence
Sources 13
- Cerebras earnings analysis: questions answered and next catalystsfinance.yahoo.com
- Cerebras Stock (CBRS) Rises to $103.68 on First Core Profit and Microsoft Deal; $143 Target in Sight - TradingNEWSnews.google.com
- Cerebras: An Absolute Game Changer (NASDAQ:CBRS) - Seeking Alphanews.google.com
- Biggest stock movers Friday: CBRS, MOD, and more - Seeking Alphanews.google.com
- Cerebras Systems Inc. (CBRS) Q3 2026 Earnings Call Transcriptseekingalpha.com
- 12 Information Technology Stocks Moving In Friday's Pre-Market Sessionfinnhub.io
- Needham Maintains Buy on Cerebras Systems, Lowers Price Target to $200finnhub.io
- Cerebras (CBRS) Stock Is Trending Pre-Market: Here's Whyfinnhub.io
- What Cerebras Systems (CBRS) Said on Its Q3 Earnings Callfinnhub.io
- Compared to Estimates, Cerebras (CBRS) Q3 Earnings: A Look at Key Metricsnasdaq.com
- Cerebras Systems Inc. Q3 2026 Earnings Call: Live Updates of $CRBS Earnings, Stock Forecastfinnhub.io
- Cerebras Systems (CBRS) Stock Could Be Above Fair Value On Investor Probefinnhub.io
- Cerebras Adds Microsoft Partnership to Diversify Beyond OpenAIfinnhub.io
Our call
Buy moredated Nov 13, 2026
Cerebras Systems' sales grew 112% over the past year, and the stock rose 21% over the past five trading days after its Nov 12 report beat profit forecasts by 200%. We'd stop buying if Cerebras Systems' next report shows sales growth below 56% or misses profit forecasts.
Other moves on Nov 13
- SPCE−31.1%Virgin Galactic tumbles on financing plans and delayed flights
- MOD+27.9%Samsung Acquisition Talks Send Modine Shares Surging
- TNDM+14.5%Health Canada Expands Tandem’s Insulin Pump Approvals
- NU+11.7%Nu Holdings jumps after record profit and strong Q3 growth
- NBIS−10.0%Nebius selloff reflects higher spending and weaker near-term outlook
- SLS+9.8%SELLAS Advances Toward Transformative AML Trial Results